about
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionMolecular mechanisms underlying β-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cellsPharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative DiseasesLaminin 211 inhibits protein kinase A in Schwann cells to modulate neuregulin 1 type III-driven myelinationRelaxant and anti-inflammatory effect of two thalidomide analogs as PDE-4 inhibitors in pregnant rat uterusSudachitin, a polymethoxyflavone from Citrus sudachi, suppresses lipopolysaccharide-induced inflammatory responses in mouse macrophage-like RAW264 cells.Transforming growth factor (TGF)-β-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit α (PKACα) and X-linked protein kinase (PRKX).Activation of cyclic adenosine monophosphate-dependent protein kinase a signaling prevents liver ischemia/reperfusion injury in miceElevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivoRegulation of the NF-κB-Mediated Transcription of Inflammatory Genes.Resveratrol prevents ammonia toxicity in astroglial cellsLow-power laser irradiation suppresses inflammatory response of human adipose-derived stem cells by modulating intracellular cyclic AMP level and NF-κB activityCross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window.Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.H5N1 Virus Hemagglutinin Inhibition of cAMP-Dependent CFTR via TLR4-Mediated Janus Tyrosine Kinase 3 Activation Exacerbates Lung Inflammation.Resveratrol as a calorie restriction mimetic: therapeutic implications.Caffeine Mitigates Lung Inflammation Induced by Ischemia-Reperfusion of Lower Limbs in Rats.Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokinesMetabolic benefits of inhibiting cAMP-PDEs with resveratrol.Pituitary adenylate cyclase-activating polypeptide (PACAP) promotes both survival and neuritogenesis in PC12 cells through activation of nuclear factor κB (NF-κB) pathway: involvement of extracellular signal-regulated kinase (ERK), calcium, and c-REPhosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases.Herpes simplex virus US3 tegument protein inhibits Toll-like receptor 2 signaling at or before TRAF6 ubiquitinationTulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.Aryl-1,3,5-triazine ligands of histamine H4 receptor attenuate inflammatory and nociceptive response to carrageen, zymosan and lipopolysaccharide.β₂-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations.The Glyoxalase System and Methylglyoxal-Derived Carbonyl Stress in Sepsis: Glycotoxic Aspects of Sepsis Pathophysiology.Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases.Nuclear translocation of nuclear factor kappa B is regulated by G protein signaling pathway in arsenite-induced apoptosis in HBE cell line.Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway.Docosahexaenoic acid differentially affects TNFα and IL-6 expression in LPS-stimulated RAW 264.7 murine macrophages.Prostaglandin E₂-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells.β1 -adrenergic receptor autoantibodies from heart failure patients enhanced TNF-α secretion in RAW264.7 macrophages in a largely PKA-dependent fashion.Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.cAMP-dependent activation of protein kinase A attenuates respiratory syncytial virus-induced human airway epithelial barrier disruption.Bacterial Nucleotidyl Cyclase Inhibits the Host Innate Immune Response by Suppressing TAK1 Activation.The interplay between cyclic AMP, MAPK, and NF-κB pathways in response to proinflammatory signals in microglia.Protein kinase A phosphorylates NCoR to enhance its nuclear translocation and repressive function in human prostate cancer cells.G protein-coupled receptor gpr34l mutation affects thrombocyte function in zebrafish.
P2860
Q26771954-A802408E-D182-4ED2-B5D1-CB417BD873F1Q28083146-FD323A6B-264C-4C34-B350-9F466E280C4DQ33679220-4D512486-3AC8-4367-9244-AA0A7D68134BQ33821677-6CBF8BE3-76ED-4642-9E56-9147E688B42BQ33899061-654C91A6-DFC4-4F15-AD62-C2E04273879CQ34031267-4298EB44-5C8C-4EAA-BB9F-DA1457BEC4D6Q34107219-B40D2BD1-3895-43FC-954A-94B00ACAC1C2Q34292003-989098F2-EC25-435A-AF52-3729DAA8BB4CQ34365776-B0FE6C6C-9E17-4AE6-AF0C-AACCE7176074Q34391237-A0C5BBB3-B131-4481-AC0F-408015574EB3Q34409102-E3907B97-1A54-494A-B0B1-AE59BB56131CQ34533205-A37CB547-3DD0-4C3B-91E3-AA4A4F3A57DBQ34559110-05E45C21-F540-42DA-93E3-4701F66A43CEQ35377816-9FB5680D-1477-448C-A29F-5A45F5C773E6Q35439638-9A81C491-2FD5-436F-885F-D6A27FA049FDQ35620767-1D076532-2490-4F0B-8A91-99272E0804B9Q35707109-4027E7B8-FE90-4D11-AC65-7DB08ECD2B02Q36291200-764BD626-8B4B-49C3-BE1B-8BD16944A781Q36328984-DE8AB799-EA13-4B6D-B56D-F6B384973F8AQ36457510-B07EE888-EF4C-475B-AF05-FE4516E69341Q36719168-BC33E7D6-6AAC-4369-92B2-27F2724A5E76Q36873611-DFA316E6-88D7-4EB1-A3B1-EBDF3F7DF4B3Q36923514-D2552D74-3A6C-4B25-BA4C-4ACD2CBE389EQ37260879-ECC475D6-C7EA-461F-9221-2209E8441E4CQ37328046-CE81DBD4-E8DB-4C44-A13F-6D15EC817A93Q37553620-54364C38-9B20-48EE-9C7F-E2607DCBCBD3Q37616740-71F185DE-8808-45EA-ACE1-FD1D7C635A67Q37729333-0EE81427-2D58-4603-9269-45DBD391CA55Q38205932-898D71E3-1524-429A-B7E5-656FF78F0C92Q38840886-FC321FAD-98F8-4F1F-9B07-FD9F7383DE0AQ38877326-909200D5-93B8-4A2F-8FB9-571B932E94E4Q38881211-F8B1BE87-AE5D-4358-9E82-3929034FE3D9Q39211129-6BCB32D5-08E2-4FE8-B1D3-5B9449BB6B26Q39342487-247BE214-A608-4B75-B239-7B560D779C51Q39809596-2654DC69-6288-4422-88AA-C92766915A8DQ40101277-93A635C1-D07C-4DBD-9945-20B18F0EFD95Q40157206-B37313B5-E619-47C7-986B-55D22B0ED2C2Q42241217-257F163D-88C0-448B-8F02-7811FC803C7CQ45896408-E2D31929-4C59-4E6D-A6E4-4E76339B0F55Q47261871-AF90357C-05C9-4DB3-826C-09DD3A809807
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclic AMP: a selective modulator of NF-κB action.
@en
Cyclic AMP: a selective modulator of NF-κB action.
@nl
type
label
Cyclic AMP: a selective modulator of NF-κB action.
@en
Cyclic AMP: a selective modulator of NF-κB action.
@nl
prefLabel
Cyclic AMP: a selective modulator of NF-κB action.
@en
Cyclic AMP: a selective modulator of NF-κB action.
@nl
P2093
P2860
P1476
Cyclic AMP: a selective modulator of NF-κB action
@en
P2093
Anneleen Spooren
Guy Haegeman
Krzysztof Kolmus
Ron Kooijman
Sarah Gerlo
P2860
P2888
P304
P356
10.1007/S00018-011-0757-8
P50
P577
2011-07-09T00:00:00Z